Looking to publish in ACS Pharmacology & Translational Science? Livewrite integrates seamlessly with Word to help you write, edit, and format faster.
Try Livewrite NowACS Pharmacology & Translational Science reports advances in molecular and biological science, from basic and preclinical studies to clinical trials.
Looking to publish in ACS Pharmacology & Translational Science? Livewrite integrates seamlessly with Word to help you write, edit, and format faster.
Try Livewrite NowSubmission Instructions
ACS Pharmacology & Translational Science accepts the following article types. Click on an article type to view submission instructions.
Article
Review
Full Research Articles
Letter
Communications
Mini-Reviews
Recent Publications
A Simple and Cost-Effective Electrochemical Assay for Heart Failure Prognosis Using Soluble Suppression of Tumorigenicity 2-Specific Nanobodies
Suwitchaya Sirimanakul, Joseph D. Hurley, Nakarin Vutipow, Fabien Loison, Anongnard Kasorn, Lueacha Tabtimmai, Pinpunya Riangrungroj, Jeerapond Leelawattanachai, Teetouch Ananwattanasuk, Napachanok Swainson, Kiattawee Choowongkomon, Andrew C. Kruse, Dujduan Waraho-Zhmayev
Recent Developments in the Diagnosis and Treatment of Disseminated and Rare Melanoma with Radiotheranostics
Rüdiger M. Exner, Jason S. Lewis, Lisa Bodei, Naga Vara Kishore Pillarsetty
A Novel Nitric Oxide Donor Induced Ferroptosis in Drug-Resistant Ovarian Cancer Cells through Lysosomal Iron Metabolism Regulation and Lipid Peroxidation
Jiachen Weng, Fan Cao, Xiufan Wu, Yunke Long, Weijie Wang, Yuxin Jiang, Ying Chen, Hongrui Liu
A New Nitroimidazole-Based Drug Attenuates Skeletal Myositis and Overcomes Benznidazole Resistance in Experimental Chagas Disease
Graziela Domingues De Almeida Lima, Elda Gonçalves-Santos, Monique Dias Benedetti, Thiago Donizeth Silva, Aristides Pinheiro, Silvânia Mól Pelinsari, Luis Felipe Cunha dos Reis, Reggiani Vilela Gonçalves, Ivo Santana Caldas, Lucas Lopardi Franco, Rômulo Dias Novaes
Iminostilbene, a Carbamazepine Intermediate, Alleviates Myocardial Fibrosis after Myocardial Infarction via Targeting Galectin3
Na Li, JiaHui Zhou, Zhihui Wang, Min Wang, Yu Tian, Guibo Sun
Frequently asked questions
How long does it take to publish?
Submission to first editorial decision: 4.1 median days; submission to first decision with peer review: 42.1 median days; submission to accept: 91.7 median days; accept to ASAP publication: 10 median days.
Reformat to ACS Pharmacology & Translational Science using Livewrite PremiumIs a cover letter required?
A cover letter must accompany every manuscript submission. It must include the manuscript title, corresponding author, all authors, a statement of suitability for the journal, whether the manuscript was discussed with an editor before submission, and a short lay summary.
Reformat to ACS Pharmacology & Translational Science using Livewrite PremiumWhat are the publication costs?
Immediate open access is available with an article publishing charge. Hybrid journals may offer a reduced APC for 12-month embargo open access. Zero-embargo green open access uses a $2,500 USD article development charge. Institutional agreements, country discounts, and waivers may reduce or cover charges.
Reformat to ACS Pharmacology & Translational Science using Livewrite Premium